---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-067062"
form_type: "8-K"
ticker: "ATEC"
cik: "0001350653"
company_name: "Alphatec Holdings, Inc."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:44:49.576412+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Alphatec FY2025 revenue $764M (+25% YoY); guides FY2026 ~$890M, raises EBITDA guidance

## Summary
- Full-year 2025 total revenue $764M (+25% YoY); GAAP net loss $143M; non-GAAP net income $8M.
- Q4 2025 revenue $213M; adjusted EBITDA $33M (16% margin), expanding 390 bps YoY; positive Q4 free cash flow $8M.
- FY2026 guidance: revenue ~$890M (+17%); adj. EBITDA ~$134M (15% of rev, up from $130M); FCF >=$20M.
- Surgical revenue $190M in Q4 (+21% YoY); net new surgeon users +23% in Q4, +20% full year.
- Valence intraoperative platform cleared and released; EOS Insight proliferation noted.

## SEC filing metadata
- accession: 0001193125-26-067062
- form_type: 8-K
- ticker: ATEC
- cik: 0001350653
- company_name: Alphatec Holdings, Inc.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1350653/000119312526067062/0001193125-26-067062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1350653/000119312526067062/atec-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-067062
- JSON: https://secwatch.observer/filing/0001193125-26-067062.json
- Plain text: https://secwatch.observer/filing/0001193125-26-067062.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
